News For Diagnostic Substances


Reviewing Navidea Biopharmaceuticals Inc (NAVB)'s and Minerva Neurosciences Inc. (NASDAQ:NERV)'s results - The FinHeadLines

Reviewing Navidea Biopharmaceuticals Inc (NAVB)'s and Minerva Neurosciences Inc. (NASDAQ:NERV)'s results  The FinHeadLines

Navidea Biopharmaceuticals Inc (NYSEAMERICAN:NAVB) and Minerva Neurosciences Inc. (NASDAQ:NERV) have been rivals in the Biotechnology for quite ...

Google 3/19/2019 7:31:23 PM

The Factor Everyone Ignores: Gilead Sciences, Inc. (GILD), Altaba Inc. (AABA) - Post Analyst

The Factor Everyone Ignores: Gilead Sciences, Inc. (GILD), Altaba Inc. (AABA)  Post Analyst

Gilead Sciences, Inc. (NASDAQ:GILD) has a price-to-sales ratio of 3.77, well below its Biotechnology: Biological Products (No Diagnostic Substances) ...

Google 3/19/2019 6:00:00 PM

Navidea Biopharmaceuticals Inc (NAVB) and Mersana Therapeutics Inc. (NASDAQ:MRSN) Comparing side by side - Thе Mоnіtоr

Navidea Biopharmaceuticals Inc (NAVB) and Mersana Therapeutics Inc. (NASDAQ:MRSN) Comparing side by side  Thе Mоnіtоr

Navidea Biopharmaceuticals Inc (NYSEAMERICAN:NAVB) and Mersana Therapeutics Inc. (NASDAQ:MRSN) compete with each other in the Biotechnology ...

Google 3/19/2019 5:57:08 PM

Montgomery doctor accused of overprescribing opioids, other controlled substances - WSFA

Montgomery doctor accused of overprescribing opioids, other controlled substances  WSFA

MONTGOMERY, AL (WSFA) - A superseding indictment handed down in March charges Dr. Richard Stehl with 26 counts, including 11 counts of distribution of a ...

Google 3/19/2019 5:25:00 PM

Navidea Biopharmaceuticals Inc (NAVB)'s Financial Results Comparing With Cellectar Biosciences Inc. (NASDAQ:CLRB) - Port Courier

Navidea Biopharmaceuticals Inc (NAVB)'s Financial Results Comparing With Cellectar Biosciences Inc. (NASDAQ:CLRB)  Port Courier

Navidea Biopharmaceuticals Inc (NYSEAMERICAN:NAVB) and Cellectar Biosciences Inc. (NASDAQ:CLRB) have been rivals in the Biotechnology for quite ...

Google 3/19/2019 2:52:56 PM


Immunoprotein Diagnostic Testing Market Archives - NewsTender

Immunoprotein Diagnostic Testing Market Archives  NewsTender

Immunoprotein Diagnostic Testing Market Landscape By Manufacturing Base, Trends, Influence factors, Revenue, Wholesalers, Opportunities and Forecasts ...

Google 3/19/2019 2:29:00 PM

As Acceleron Pharma INC (XLRN) Shares Declined, Great Point Partners LLC Increased Stake by $5.11 Million - The EN Bulletin

As Acceleron Pharma INC (XLRN) Shares Declined, Great Point Partners LLC Increased Stake by $5.11 Million  The EN Bulletin

Big Money Sentiment increased to 1.11 in 2018 Q4. It has change of 0.08, from 2018Q3's 1.03. The ratio is positive due to XLRN positioning: 19 sold and 43.

Google 3/19/2019 1:46:58 PM

 1 2 3 4 5  ...